发明名称 Anti-erbb3 antibody for use in a method for treating a patient having a neoplastic tumor
摘要 <p>The invention provides methods for treating patients which methods comprise methods for predicting responses of cells, such as tumor cells, to treatment with therapeutic agents. These methods involve measuring, in a sample of the cells, levels of one or more components of a cellular network and then computing a Network Activation State (NAS) or a Network Inhibition State (NIS) for the cells using a computational model of the cellular network. The response of the cells to treatment is then predicted based on the NAS or NIS value that has been computed. The invention also comprises predictive methods for cellular responsiveness in which computation of a NAS or NIS value for the cells (e.g., tumor cells) is combined with use of a statistical classification algorithm. Biomarkers for predicting responsiveness to treatment with a therapeutic agent that targets a component within the ErbB signaling pathway are also provided.</p>
申请公布号 IL210865(A) 申请公布日期 2014.04.30
申请号 IL20110210865 申请日期 2011.01.25
申请人 MERRIMACK PHARMACEUTICALS INC. 发明人
分类号 主分类号
代理机构 代理人
主权项
地址
您可能感兴趣的专利